Efficacy and safety of the APE (actinomycin D, cisplatin, etoposide) regimen for the management of high-risk gestational trophoblastic neoplasia.

被引:0
|
作者
Lhomme, Catherine
Even, Caroline
Duvillard, Pierre
Pautier, Patricia
Floquet, Anne
Kerbrat, Pierre
Troalen, Frederic
Rey, Annie
Balleyguier, Corinne
Morice, Philippe
Fizazi, Karim
Droz, Jean Pierre
机构
[1] Inst Gustave Roussy, Villejuif, France
[2] Inst Gustave Roussy, Dept Pathol, Villejuif, France
[3] Inst Bergonie, Bordeaux, France
[4] Ctr Eugene Marquis, Rennes, France
[5] Inst Gustave Roussy, Dept Med Oncol, Villejuif, France
[6] Ctr Leon Berard, F-69373 Lyon, France
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5028
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Importance of salvage therapy in the management of high-risk gestational trophoblastic neoplasia (GTN)
    Lurain, J.
    Schink, J.
    [J]. GYNECOLOGIC ONCOLOGY, 2012, 125 : S67 - S68
  • [32] The efficacy and safety of 5-fluorouracil/cisplatin/vincristine as a multi-agent chemotherapy regimen in gestational trophoblastic neoplasia
    Wang, Lu
    Wang, Qian
    Xu, Zhen
    Yang, Linli
    Wang, Wuliang
    [J]. FRONTIERS IN ONCOLOGY, 2023, 13
  • [33] Results with EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) chemotherapy in gestational trophoblastic neoplasia
    Turan, T
    Karacay, O
    Tulunay, G
    Boran, N
    Koc, S
    Bozok, S
    Kose, MF
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2006, 16 (03) : 1432 - 1438
  • [34] Etoposide-Actinomycin as Salvage Regimen for the Treatment of Nonmetastatic and Low-Risk Metastatic Gestational Trophoblastic Neoplasia Experience at the Philippine General Hospital
    Nevado-Gammad, Mariel S.
    Soriano-Estrella, Agnes L.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 (05) : 977 - 983
  • [35] Management of high-risk gestational trophoblastic disease
    Lurain, JR
    [J]. JOURNAL OF REPRODUCTIVE MEDICINE, 1998, 43 (01) : 44 - 52
  • [36] Human chorionic gonadotropin (hCG) regression normograms for patients with high-risk gestational trophoblastic neoplasia treated with EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide and vincristine) chemotherapy
    Lybol, C.
    Westerdijk, K.
    Sweep, F. C. G. J.
    Ottevanger, P. B.
    Massuger, L. F. A. G.
    Thomas, C. M. G.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 (11) : 2903 - 2906
  • [37] Spontaneous Uterine Rupture of a High-Risk Gestational Trophoblastic Neoplasia
    Alkhanbouli, Maryam
    Hana, Tommy
    Laframboise, Stephane
    Bouchard-Fortier, Genevieve
    [J]. JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA, 2024, 46 (07)
  • [38] Pulmonary resection in the treatment of high-risk gestational trophoblastic neoplasia
    Kanis, M. J.
    Lurain, J. R., III
    [J]. GYNECOLOGIC ONCOLOGY, 2015, 137 : 39 - 40
  • [39] MANAGEMENT OF HIGH-RISK GESTATIONAL TROPHOBLASTIC DISEASE
    SURWIT, EA
    [J]. JOURNAL OF REPRODUCTIVE MEDICINE, 1987, 32 (09) : 657 - 662
  • [40] MANAGEMENT OF HIGH-RISK GESTATIONAL TROPHOBLASTIC TUMORS
    Daoudi, S.
    Adrif, I
    Laanaz, S.
    Errihani, H.
    [J]. TUMORI JOURNAL, 2020, 106 : 41 - 41